**Core Concept**
Phenytoin therapy can lead to macrocytic anemia due to inhibition of folate metabolism, resulting in impaired DNA synthesis and erythropoiesis.

**Why the Correct Answer is Right**
Phenytoin interferes with folate metabolism by competing with dihydrofolate reductase (DHFR) enzyme, thereby reducing tetrahydrofolate (THF) levels. THF is essential for DNA synthesis and erythropoiesis. The decreased THF levels lead to macrocytic anemia characterized by increased mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH). In this case, Kamla's MCV is 102 fl, and MCH is 40 pg/dl, indicating macrocytic anemia.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not relevant to the clinical scenario described. The symptoms and lab findings do not suggest iron deficiency anemia.
* **Option B:** This option is incorrect as it does not relate to the specific effects of phenytoin on folate metabolism and erythropoiesis.
* **Option D:** This option is not supported by the lab findings, which indicate macrocytic anemia rather than normocytic anemia.

**Clinical Pearl / High-Yield Fact**
Macrocytic anemia can also be caused by other medications like methotrexate, sulfonamides, and pyrimethamine, which inhibit folate metabolism. Always consider the patient's medication history when evaluating anemia.

**Correct Answer:** C. Macrocytic anemia due to phenytoin-induced folate deficiency.